336 related articles for article (PubMed ID: 15637347)
21. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.
O'Reilly M; Marshall E; Macgillivray T; Mittal M; Xue W; Kenyon CJ; Brown RW
J Am Soc Nephrol; 2006 Sep; 17(9):2402-13. PubMed ID: 16899520
[TBL] [Abstract][Full Text] [Related]
22. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
Sohara E; Uchida S
Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of regulation of renal ion transport by WNK kinases.
Huang CL; Yang SS; Lin SH
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):519-25. PubMed ID: 18695394
[TBL] [Abstract][Full Text] [Related]
24. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
25. WNK kinases: molecular regulators of integrated epithelial ion transport.
Kahle KT; Wilson FH; Lalioti M; Toka H; Qin H; Lifton RP
Curr Opin Nephrol Hypertens; 2004 Sep; 13(5):557-62. PubMed ID: 15300163
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.
Bergaya S; Vidal-Petiot E; Jeunemaitre X; Hadchouel J
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):39-45. PubMed ID: 22080857
[TBL] [Abstract][Full Text] [Related]
27. WNK3, a kinase related to genes mutated in hereditary hypertension with hyperkalaemia, regulates the K+ channel ROMK1 (Kir1.1).
Leng Q; Kahle KT; Rinehart J; MacGregor GG; Wilson FH; Canessa CM; Lifton RP; Hebert SC
J Physiol; 2006 Mar; 571(Pt 2):275-86. PubMed ID: 16357011
[TBL] [Abstract][Full Text] [Related]
28. A unifying mechanism for WNK kinase regulation of sodium-chloride cotransporter.
Huang CL; Cheng CJ
Pflugers Arch; 2015 Nov; 467(11):2235-41. PubMed ID: 25904388
[TBL] [Abstract][Full Text] [Related]
29. [New perspective on the role of WNK1 and WNK4 in the regulation of NaCl reabsorption and K(+) secretion by the distal nephron].
Rafael C; Chavez-Canales M; Hadchouel J
Med Sci (Paris); 2016 Mar; 32(3):274-80. PubMed ID: 27011246
[TBL] [Abstract][Full Text] [Related]
30. Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.
Mayan H; Munter G; Shaharabany M; Mouallem M; Pauzner R; Holtzman EJ; Farfel Z
J Clin Endocrinol Metab; 2004 Aug; 89(8):4025-30. PubMed ID: 15292344
[TBL] [Abstract][Full Text] [Related]
31. Unique chloride-sensing properties of WNK4 permit the distal nephron to modulate potassium homeostasis.
Terker AS; Zhang C; Erspamer KJ; Gamba G; Yang CL; Ellison DH
Kidney Int; 2016 Jan; 89(1):127-34. PubMed ID: 26422504
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport.
Yang CL; Zhu X; Wang Z; Subramanya AR; Ellison DH
J Clin Invest; 2005 May; 115(5):1379-87. PubMed ID: 15841204
[TBL] [Abstract][Full Text] [Related]
33. WNK4-mediated regulation of renal ion transport proteins.
Peng JB; Warnock DG
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F961-73. PubMed ID: 17634397
[TBL] [Abstract][Full Text] [Related]
34. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
Glover M; O'Shaughnessy KM
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
[TBL] [Abstract][Full Text] [Related]
35. Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.
Hadchouel J; Soukaseum C; Büsst C; Zhou XO; Baudrie V; Zürrer T; Cambillau M; Elghozi JL; Lifton RP; Loffing J; Jeunemaitre X
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18109-14. PubMed ID: 20921400
[TBL] [Abstract][Full Text] [Related]
36. WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl- -transporting epithelia.
Choate KA; Kahle KT; Wilson FH; Nelson-Williams C; Lifton RP
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):663-8. PubMed ID: 12522152
[TBL] [Abstract][Full Text] [Related]
37. Role of WNK4 and kidney-specific WNK1 in mediating the effect of high dietary K
Wu P; Gao ZX; Su XT; Ellison DH; Hadchouel J; Teulon J; Wang WH
Am J Physiol Renal Physiol; 2018 Aug; 315(2):F223-F230. PubMed ID: 29667910
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms for hypercalciuria in pseudohypoaldosteronism type II-causing WNK4 knock-in mice.
Yang SS; Hsu YJ; Chiga M; Rai T; Sasaki S; Uchida S; Lin SH
Endocrinology; 2010 Apr; 151(4):1829-36. PubMed ID: 20181799
[TBL] [Abstract][Full Text] [Related]
39. Human hypertension caused by mutations in WNK kinases.
Wilson FH; Disse-Nicodème S; Choate KA; Ishikawa K; Nelson-Williams C; Desitter I; Gunel M; Milford DV; Lipkin GW; Achard JM; Feely MP; Dussol B; Berland Y; Unwin RJ; Mayan H; Simon DB; Farfel Z; Jeunemaitre X; Lifton RP
Science; 2001 Aug; 293(5532):1107-12. PubMed ID: 11498583
[TBL] [Abstract][Full Text] [Related]
40. A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene.
Golbang AP; Murthy M; Hamad A; Liu CH; Cope G; Van't Hoff W; Cuthbert A; O'Shaughnessy KM
Hypertension; 2005 Aug; 46(2):295-300. PubMed ID: 15998707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
